NUR 3105- Intro to Pharmacology: Neuropharmacology: Adrenergic and Cholinergic Meds Lecture

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/87

encourage image

There's no tags or description

Looks like no tags are added yet.

88 Terms

1
New cards

Nervous System Physiology- Overview: CNS

  • Brain

  • Spinal Cord


2
New cards

Nervous System Physiology-Overview: Autonomic Nervous System


  • Automatic, uncontrolled processes

  • Sympathetic vs Parasympathetic


3
New cards

Neuropharmacologic Drug:

Works by influencing receptor activity on target cells

4
New cards

Autonomic Nervous System: Sympathetic (Adrenergic)

Fight or Flight

  • Responds to outside stimuli

  • Receptors respond to catecholamines:

    • Epinephrine

    • Norepinephrine

    • Dopamine


5
New cards

Autonomic Nervous System: Parasympathetic (Cholinergic)

Rest and Digest

  • Run in the background

  • Receptors respond to:

    • Acetylcholine


6
New cards

Cholinergic Receptors:

Respond to Neurotransmitter Acetlycholine

7
New cards

Cholinergic Receptors: Nicotinic N & M

Nicotinic N = Neuron = on postganglionic neuron and adrenal medulla

Nicotinic M = Muscle = on skeletal muscle

8
New cards

Cholinergic Receptors: Muscarinic

On organs regulated by parasympathetic system including smooth muscle and glands

• M1 = CNS & Salivary glands

• M2 = Heart

• M3 = Eyes, salivary glands, GI, urinary bladder, blood vessels

• M4 = CNS (motor control/cognition)

• M5 = CNS (dopaminergic areas of brain)

9
New cards

Sympathetic (Adrenergic Receptors)

Adrenergic = Adrenals, Adrenaline and Epinephrine

• Dopamine

• Alpha 1

• Alpha 2

• Beta 1

• Beta 2

10
New cards

Adrenergic System: Fight or Flight (Alpha 1 Receptors) produce:

  • Mydriasis (Pupil Dilation)

  • Constriction of arterioles supplying skin, viscera, and mucous membranes

  • Venous constriction to increase venous return

  • Contraction of prostatic capsule and bladder trigone and sphincter

  • Uterine contraction and ejaculation


11
New cards

Adrenergic System: Fight or Flight (Alpha 2 Receptors)

(Inhibitory receptor to stop response)

• Inhibits neurotransmitter release at presynaptic nerve terminals

12
New cards

Adrenergic System: Fight or Flight (Beta 1 Receptors)

(Mnemonic: You only have ONE HEART)

• Increased rate, conduction, and force of contraction on heart

• Releases renin from kidney

13
New cards

Adrenergic System: Fight or Flight (Beta 2 Receptors)

(Mnemonic: You have TWO LUNGS)

• Dilation of arterioles supplying heart, lungs, and skeletal muscle

• Dilation of bronchi

• Enhanced glycogenolysis in the liver

• Uterine Relaxation

14
New cards

Adrenergic System: Fight or Flight (Dopamine Receptors)

Dilation of Kidney Vasculature

15
New cards

Adrenergic Effects: Alpha Receptors

Alpha Receptor Result in:

• Better vision (more light gets in)

• Blood redirected to essential functions

• Increased Blood Pressure via improved venous return

• Delayed bladder emptying

• Uterine Contraction and Ejaculation

16
New cards

Adrenergic Effects: Beta Receptors

Increased cardiac output via increased heart rate and activation of RAAS

• Increased blood flow to essential organs (heart, lungs, skeletal muscle)

• Improved oxygenation through bronchodilation

• Ready supply of fuel (glucose) via glycogenolysis

• Improved renal perfusion

17
New cards

Preterm Labor: Adrenergic Effects

Beta 2 causes uterine relaxation, and Beta 2 Agonists have been used in the past to arrest pre-term labor.

  • New evidence shows babies may have higher risk for asthma later in life


18
New cards

Cholinergic Drug Categories: Muscarinic Agonist

  • Bethanechol

  • Pilocarpine


19
New cards

Cholinergic Drug Categories: Muscarinic Antagonists

  • Atropine

  • Oxybutynin


20
New cards

Cholinergic Drug Categories: Cholinesterase Inhibitors

  • Neostigmine

  • Physostigmine

  • Edrophonium


21
New cards

Muscarinic Agonists: AKA?

“Parasympathomimetics” - mimics effects of parasympathetic nervous system

  • Muscarinic agonists bind to muscarinic receptors and cause receptor activation


22
New cards

Muscarinic Agonists: NTN

Bethanechol (Urecholine, Duvoid)

23
New cards

Muscarinic Agonists: Bethanechol (Urecholine, Duvoid) MOA

Stimulates muscarinic receptors to allow bladder to empty

  • Indication: Urinary Retention in post-op or postpartum PTs


24
New cards

Muscarinic Agonists: Bethanechol (Urecholine, Duvoid) Pharmacokinetics

Given PO, Polar (so crosses membranes poorly)

  • Not well absorbed. Other unknown PKs.


25
New cards

Muscarinic Agonists: Bethanechol (Urecholine, Duvoid) AE

  • Hypotension & Bradycardia

  • Excessive salivation, GI motility & diarrhea

  • Bronchoconstriction (contraindicated in asthma)


26
New cards

Muscarinic Agonists: Pilocarpine

Binds to smooth muscle and causes smooth muscle contraction

  • Indications:

    • Glaucoma: binds to smooth muscle cells in the eye (iris ciliary) to cause constriction to promote aqueous humor flow

    • Xerostomia: promotes salivation by stimulating salivary secretion


27
New cards

Muscarinic Agonists: Pilocarpine Pharmacokinetics

Administered via:

  • Solution (eye drops), gel for (glaucoma)

  • Tablets for (xerostomia)


28
New cards

Muscarinic Agonists: Pilocarpine Pharmacokinetics Implications

Avoid high fat foods with oral admin

  • no adequate studies in children or those lactating – unknown Pks


29
New cards

Muscarinic Agonists: Pilocarpine Pharmacokinetics AE

  • GI motility

  • N/V/D

  • Increased sweating


30
New cards

Muscarinic Antagonist: Atropine

Blocks Muscarinic Receptors yielding anticholinergic effects

  • Indications:

    • Dries up secretions (useful in surgery)

    • Increases HR (drug of choice for bradycardia)

    • Pupil dilation (useful for eye exams)

    • Muscarinic agonist poisoning (poison mushrooms)


31
New cards

Muscarinic Antagonist: Atropine AE

  • Blurred vision, increased IOP

  • Tachycardia

  • Urinary retention, constipation

  • Xerostomia (dry mouth)

  • anhidrosis (absence of sweating)


32
New cards

Treatment for OAB BEFORE Pharmacologic interventions

Nonpharmacologic interventions first:

• Bladder training (timed voiding and fluid intake)

• Kegel exercises

• Avoid bladder irritants such as caffeine

33
New cards

Muscarinic Antagonist For OAB: Pharmacology Therapy NTN

Oxybutynin (Ditropan XL)

34
New cards

Muscarinic Antagonist For OAB: Oxybutynin (Ditropan XL)

Block ACh at M3 receptors

• Relax bladder detrusor and contract trigone and sphincter

35
New cards

Muscarinic Antagonist For OAB: Oxybutynin (Ditropan XL) AE

Anticholinergic symptoms

• Xerostomia (dry mouth)

• Constipation

• Blurred vision

36
New cards

Muscarinic Antagonist For OAB: Oxybutynin (Ditropan XL) Pharmacokinetics

  • Lipid-soluble - can enter the CNS and cross membranes

  • Short half-life - Multiple Doses/Day

• Significant first-pass metabolism


37
New cards

Muscarinic Antagonist For OAB: Oxybutynin (Ditropan XL) Administration


• Long-acting formulations available (equal efficacy with reduced side effects)

• Extended-release tablets

• Transdermal patch

38
New cards

Cholinesterase Inhibitors: Main Indicator

Myasthenia Gravis (grave muscle weakness)

  • Autoimmune disorder that destroys nicotinic (M) receptors on skeletal muscle, causing muscle weakness

    • Also (Reversal of nondepoloarizing neuromuscular blockade)


39
New cards

Cholinesterase Inhibitors: MOA

  • Inhibits cholinesterase preventing breakdown of ACh

  • Increases bioavailability of Ach

  • Ensures as many Nicotinic M receptors are activated as possible


40
New cards

Cholinesterase Inhibitors: NTN

Neostigmine/Physostigmine

  • Binds to cholinesterase but takes a LONG time to breakdown


41
New cards

Cholinesterase Inhibitors: Neostigmine/Physostigmine Pharmacokinetics

  • IM, IV, SC, poor oral absorption


42
New cards

Cholinesterase Inhibitors: Neostigmine/Physostigmine Therapeutic vs Toxic Dose

  • Therapeutic doses =

    • CNS excitation and skeletal muscle contraction ( ACh)


  • Toxic doses =

    • CNS Depression and skeletal muscle weakness


43
New cards

Cholinergic Crisis: SLUD

  • Salivation

  • Lacrimaton

  • Urination

  • Defacation


44
New cards

Cholinergic Crisis: SLUDGE AND THE KILLER Bs

• Salivation

• Lacrimation

• Urination

• Diaphoresis/Diarrhea

• Gastrointestinal cramping

• Emesis

• Bradycardia

• Bronchospasm

• Bronchorrhea

45
New cards

Cholinergic Crisis vs Myasthenia Crisis

Admin. Edrophonium

◦ Cholinesterase inhibitor

◦ If Ach levels and symptoms are alleviated = Myasthenic

◦ If Symptoms are intensified= Cholinergic

◦ Can be life threatening!

◦ MUST have oxygen and atropine available immediately to treat

46
New cards

Adrenergic Agonists Categories: Catecholamine Adrenergic Agonists

Epinephrine,

Norepinephrine

Dopamine

47
New cards

Adrenergic Agonists Categories: Noncatecholamine Adrenergic Agonists

Albuterol

Phenylephrine

48
New cards

Adrenergic Agonists: Catecholamines

Polar molecules

• Cannot pass membranes

• Cannot penetrate blood-brain barrier

Metabolism

  • Metabolized by enzymes Monoamine Oxidase (MAO) and COMT in intestine and liver

    • Not bioavailable following oral administration due to first-pass effect, must be given parenterally (IV, IM, SC)

• VERY short half-life; needs continuous IV infusion to maintain MEC

49
New cards

Adrenergic Agonists: Catecholamines Administration

  • Given parenterally (IV, IM, SC)

  • IV= systemic effects

  • Topical/local injection = local effects


50
New cards

Adrenergic Agonists: Epinephrine

Nonselective adrenergic agonist:

• Stimulates all alpha and beta receptors

51
New cards

Adrenergic Agonists: Epinephrine Therapeutic Uses

  • Anaphylactic shock - drug of choice EPI-PEN - IM Admin.

• Cardiopulmonary arrest

• Ventricular fibrillation

• Asthma

• Local vasoconstriction

• Adjunct for local anesthesia

52
New cards

Adrenergic Agonists: Epinephrine AE

Related to stimulation of all adrenergic receptors

• Hypertensive Crisis

• Dysrhythmias

• Angina

• Necrosis after extravasation

• Hyperglycemia

53
New cards

Adrenergic Agonists: Epinephrine Pharmacokinetics

Significant first-pass effect: must be given parenterally

  • Short half-life:

    • Anaphylaxis MUST have follow-up treatment with monitoring, steroids, antihistamines, etc. as can recur after Epipen


54
New cards

Adrenergic Agonists: Epinephrine Drug Interactions

  • MAO Inhibitors (MAOI’s)

    • Prolong/intensify effects of epinephrine

  • Tricyclic Antidepressants

    • Prolong/intensify effects

  • General anesthetics

    • Tachy dysrhythmias

  • Alpha and Beta Blockers

    • Counteract each other’s effects


55
New cards

Adrenergic Agonists: Norepinephrine (Levophed)

Norepinephrine (Levophed)

• Same as epinephrine but does not stimulate Beta-2

• No bronchodilation

• No hyperglycemia

56
New cards

Adrenergic Agonists: Norepinephrine (Levophed) Indications

Hypotension = “pressor” = vasopressor: peripheral vasoconstriction

• Increases blood pressure by increasing peripheral vascular resistance

57
New cards

Adrenergic Agonists: Dopamine (Inotropin)

Dopamine (Inotropin)

• Catecholamine and precursor to NE

• Stimulates dopamine receptors and dose-dependent beta-1 and alpha-1 stimulation

58
New cards

Adrenergic Agonists: Dopamine (Inotropin) Indication

Vasopressor used in treating shock

59
New cards

Adrenergic Agonists: Dopamine (Inotropin) Administration

IV administration only in acute care settings

• Invasive monitoring, pump

• Correct hypovolemia first

• Weight based dosing

60
New cards

Nonacatecholamine: Adrenergic Agonist Pharmacokinetics

Nonpolar:

  • Can pass through the BBB

Metabolism

  • Slowly metabolized by MAO

Given PO


61
New cards

Nonacatecholamine: Selective Adrenergic Agonist: Albuterol (ProAir, Ventolin)

Selective Beta-2 Agonist

  • Also Beta-1 Agonist at high doses

Common side-effect: tachycardia


62
New cards

Nonacatecholamine: Selective Adrenergic Agonist: Phenleyphrine

Alpha-1 Agonist:

  • Potent vasoCONSTRICTOR

Indications for Use:

  • Hypotension

  • Shock

  • Adjunct for local anesthesia

  • Nasal decongestant (Sudafed PE)

  • Pupil Dilation (Mydriasis)


63
New cards

Adrenergic ANTAGONIST Alpha 1: Blockers NTK

  • Prazosin

  • Tamulosin


64
New cards

Alpha Blockers MOA

  • Blocks Alpha-1 Receptors on Blood Vessles

  • Blocks Alpha1 receptors on Bladder and Prostate


65
New cards

Alpha Blockers: Therapeutic Uses

Essential Hypertension

BPH

66
New cards

Alpha Blockers: Prazosin (Minipress) Indications

  • Hypertension and Benign Prostatic Hyperplasia (BPH)


67
New cards

Alpha Blockers: Prazosin (Minipress) Adverse Effects

  • Orthostatic Hypotension

  • Reflex Tachycardia

  • Nasal Congestion

  • Inhibition of Ejaculation


68
New cards

Alpha Blockers: Tamsulosin (Flomax) MOA

Selective Alpha-1 Blockade

  • Only blocks alpha receptops in smooth muscle of bladder, prostate, and urethra

Indications: BPH ONLY


69
New cards

Adrenergic ANTAGONIST: Beta Blockers NTK

  • Propanolol

  • Metoprolol

  • Timolol


70
New cards

Beta Blockers:

Blocks Beta-1 and/or Beta-2 Receptors:

Therapeutic Uses:

  • Hypertention

  • Cardiac Dysrythmias

  • Hyperthyroidism

  • Migraine

  • Performance Anxiety: Stage Freight and Test Anxiety


71
New cards

Beta Blockers: Adverse Effects

  • Bracycardia

  • Hypotension

  • Bronchoconstriction

  • Mask symptoms of hypoglycemia


72
New cards

Beta Blockers: Propanaolol (Inderal) Non-Selective

Beta-1 and Beta-2 Blockade

  • Beta 1 Blockade: Therapeutic Effect

    • Reduced Heart Rate, Force of Contraction

  • Beta 2 Blockade: Adverse Effects

    • Bronchoconstriction

    • Inhibition of glycogenolysis

    • Blocks effects of epineprhine on airways


73
New cards

Beta Blockers: Propanaolol (Inderal) Non-Selective CAUTION IN PTs

  • COPD/Asthma

  • Diabetes

  • History of Severe Allergies and/or Anaphylaxis


74
New cards

Beta Blockers: Propanaolol (Inderal) Pharmacodynamics

Lipid Soluble: easily crosses membrane

  • BBB and Placenta

    • Neonate exposure: monitor for days due to Beta-1 and Beta-2 Blockade

  • Extensive First Pass Effect:

    • Only 30% bio-available with oral administration


75
New cards

Beta Blockers: Metoprolol (Lopressor)

Cardioselective (Beta-1 only) at normal doses

  • Similar PK, Side effect, and drug interactions as Propanolol except:

    • Preferred in asthma and diabetes due to selective action


76
New cards

Adrenergic ANTAGONIST: Alpha AND Beta Blockers:

  • Carvedilol

  • Labetalol


77
New cards

Beta Blockers: Carvedilol (Coreg) and Labetalol (Normodyne)

Blocks Beta 1 and Beta 2 and Selective Alpha 1

  • Alpha blocking cause peripheral vasoDILATION

  • Beta Blocking prevents reflex tachycardia and renin release


Same concerns as other alpha/beta blockers

  • Risk of hypotension/bradychardia

  • Use in caution with Asthma and Diabetes


78
New cards

Adrenergic ANTAGONIST: Central Acting Alpha2 Agonist: NTK

  • Clonidine

  • Methyldopa


79
New cards

Central Acting Alpha2 Agonist: MOA

Activated Alpha-2 receptors send a message to reduce norepinephrine synthesis

  • Less catecholamine release = VasoDILATION

    • Indicated for HTN

  • Tendency to cause excessive sedation, dizziness, orthostatic hypotension, NA ad H2O Retention


80
New cards

Central Acting Alpha2 Agonist: Clonidine (Catapres)

Inhibits sympathetic nervous system response and reduces sympathetic outflow from the CNS

  • Decrease HR, BP, vasoconstriction and vascular resistance

  • Severe rebound HTN if discontinued

  • Causes Xerostomia (dry mouth)

    • give hard candy


81
New cards

Central Acting Alpha2 Agonist: Methyldopa (Aldomet)

Converts to methylnorepinephrine and displaces norepinephrine from storage sites

  • Drug choice for pregnant women with HTN

    • Demonstrates improved outcomes without fetal harm


Hepatotoxic: Check LFTS before and during treatment

82
New cards

A patient receives a medication that results in the activation of the acetylcholine

receptors of the heart. The nurse should assess the patient for which intended

effect?

A. Decreased heart rate

B. Dysrhythmia suppression

C. Increased heart rate

D. Improved contractilit

A. Decreased heart rate

83
New cards


The nurse instructs a patient with myasthenia gravis who is taking

neostigmine [Prostigmin]. Which statement, if made by the patient to the

nurse, indicates an understanding of the instructions?

A. “The antidote for this medication is norepinephrine.”

B. “An extra dose should be taken if paralysis occurs.”

C. “A medical alert bracelet should be worn at all times.”

D. “The medication will be prescribed for 2 to 3 months

C. “A medical alert bracelet should be worn at all times.”

84
New cards

The nurse administers a medication to a patient that stimulates the function of the

parasympathetic nervous system. The nurse should assess the patient for which

intended effect?

A. Reduced esophageal motility

B. Improved bladder emptying

C. Dilation of the pupils

D. Decreased gastric secretion

B. Improved bladder emptying

85
New cards

A patient is prescribed bethanechol [Urecholine] for urinary retention. If the

patient exhibits signs of an overdose, such as increased salivation and

sweating, bradycardia, or hypotension, which medication should the nurse

administer?

A. Acetylcholine [Miochol-E]

B. Cevimeline [Evoxac]

C. Oxybutynin [Ditropan]

D. Atropine [AtroPen]


D. Atropine [AtroPen]

86
New cards

The nurse cares for a patient with myasthenia gravis. Before administering

pyridostigmine [Mestinon], it is most important for the nurse to take which

action?

A. Assess the patient’s ability to swallow a sip of water.

B. Cleanse the patient’s skin before applying the transdermal patch.

C. Ask whether the patient has an allergy to aspirin.

D. Give the patient food or milk to prevent stomach upset

A. Assess the patient’s ability to swallow a sip of water.

87
New cards

The nurse is caring for a patient who was foraging and consumed a handful of

mushrooms. The patient is now having difficulty breathing, bradycardia, and

severe hypotension. Based on the presentation, which intervention should the

nurse expect to take immediately?

A. Prepare the patient for the cath lab

B. Administer Atropine

C. Call the family members to try to identify the mushrooms

D. Alert the blood bank of the patient’s arriva

B. Administer Atropine

88
New cards


A patient who has myasthenia gravis reports extreme muscle weakness.

Which of the following medications should the nurse prepare to administer to

distinguish myasthenic crisis from cholinergic crisis?

A. Echothiophate [Phospholine iodide]

B. Edrophonium [Tensilon]

C. Atropine [AtroPen]

D. Ambenonium [Mytelase

B. Edrophonium [Tensilon]